Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic Value.
Inpyeong HwangSeung Hong ChoiChul-Kee ParkTae Min KimHye-Kyung ParkJae Kyoung WonIl Han KimSoon Tae LeeRoh-Eul YooKoung Mi KangTae Jin YunJi Hoon KimChul-Ho SohnPublished in: AJNR. American journal of neuroradiology (2019)
Baseline median K trans from nonenhancing T2 high-signal-intensity lesions could be a potential prognostic imaging biomarker in patients undergoing gross total surgical resection followed by standard therapy for glioblastoma.